Public Policy
In the wake of the Supreme Court decision on Rutledge vs. PCMA, states have introduced legislation threatening ERISA pre-emption for employer-sponsored health plans. More
Briefing
Senior Vice President, Government and Public Affairs, CVS Health
As Senior Vice President, Government and Public Affairs, CVS Health, Melissa Schulman leads the teams responsible for the public policy, regulatory, state and federal advocacy, and public affairs efforts for the enterprise and business units. She has 14 years of experience on Capitol Hill and 18 years in the private sector.
Schulman has a proven record of success steering coalitions, and draws on broad experience utilizing industry expertise to successfully navigate the nuances of Washington. She is known for her ability to build bipartisan consensus by dissecting complex issues in a way that resonates with key legislators and policymakers. Schulman has been named by Roll Call among the Top Fifty Congressional Staff and is frequently cited in political publications such as The Hill, National Journal and others.
Public Policy
ACA Returns to Court
The California vs. Texas case before the U.S. Supreme Court could help determine the future of the Affordable Care Act (ACA), and could lead to one of several different results. More
Commentary
Public Policy
If ERISA pre-emption is not upheld for self-funded ERISA plans using PBMs to administer prescription drug benefits, we believe the implications may create unsustainable complexity... More
Commentary
Government Programs and Services
The CVS Health government affairs team offers perspective on the CARES, legislation which includes provisions making it easier for consumers to access health care and financial... More
Commentary
Public Policy
With a slate of bills trying to tackle rising drug prices, CVS Health advocates for those that could help increase competition and lower drug prices; others may limit private... More
Commentary
Public Policy
Solutions such as POS rebates and $0 copay drug lists can lower costs for plans and consumers, while a one-size-fits-all approach could lead to unintended consequences, and higher... More
Briefing
Public Policy
Proposed HHS rule would eliminate rebates PBMs negotiate for Part D plans and MCOs, and may eventually affect all plans. Manufacturers would retain 15% of rebates currently... More
Briefing
Cost Management
CVS Health responded to the Administration's Blueprint on lowering drug costs and highlighted what the company does to control costs. We also recommended things the... More
Commentary